Journalism of Courage
Biocon
Follow on:
Biocon Limited: A Pioneer in Indian Biopharmaceuticals Biocon Limited, founded in 1978 by Kiran Mazumdar-Shaw, has established itself as a leading biopharmaceutical company based in Bengaluru. Its operations span a global reach, with generic active pharmaceutical ingredients (APIs) distributed acros...
Image Source : Wikipedia
- Company type Public
- Founded 1978 (47 years ago) (1978)
- Founders Kiran Mazumdar-Shaw
- Headquarters Bangalore, Karnataka, India
- Key people Kiran Mazumdar-Shaw (executive chairperson), Peter Bains (Group CEO), Siddharth Mittal (CEO & (CEO &
- Revenue ₹15,621 crore (US$1.8 billion) (FY24)
- Net income ₹1,030 crore (US$120 million) (FY24)
- Number of employees 16,545 <small>(March 2023)</small>
- Subsidiaries Biocon Biologics, Syngene International
- Website www.biocon.com
Related Other Pages:
Biocon history
Last Updated : 17/03/25, 05:12 AM
Biocon: A Journey in Biopharmaceutical Innovation Founded in 1978 by Kiran Mazumdar-Shaw with a modest US$10,000, Biocon quickly established itself as a pioneer in the Indian biotechnology sector. Early successes included becoming the first Indian company to export enzymes to the US and Europe (1979...
BIOCON NEWS
BoI Q1 net up 8.6% at R964 cr
July 27, 2013 12:56 am
Bank of India has reported 8.6 per cent rise in its net profit at Rs 964.18 crore
Indian pharma market needs strong regulatory set-up: Kiran Mazumdar-Shaw
July 27, 2013 12:13 am
Biocon has outpaced the market because we are very focussed on building brands.
Biocon to launch psoriasis drug novel biologic in July
April 28, 2013 12:15 pm
The global market for psoriasis treatments is estimated to cross USD 8 billion by 2016.
Biocon,Pfizer call off $350 mn pact
March 13, 2012 10:47 am
The deal was signed between the companies in October 2010.
BofA downgrades Biocon stock rating
January 27, 2012 12:23 pm
Bank of America has cut Biocon's target price to Rs 260 from Rs 395 citing weak outlook.
Drug giants stop supply to hospitals over pending bills
December 15, 2011 3:21 am
Hospitals in the state are facing a shortage of drugs as companies,who were awarded contracts under the new policy,have stopped supplies over stalled payment of their bills by officials in the districts.
Shaw fears shoddy govt job on rich tax
October 14, 2011 11:15 am
Kiran Mazumdar-Shaw says govt is perceived to be doing a sub-optimal job with taxpayers' funds.
Biocon eyes $1 bn revenue in next three fiscals: Shaw
September 20, 2011 7:12 pm
The firm also has plans to list its contract research and manufacturing services arm Syngene.
Licensing income did the trick for Biocon
January 22, 2011 9:35 am
Biocon reported Q3 numbers higher than our expectations almost entirely driven by higher licensing income.
Biocon soars 13%; touches all-time high
October 19, 2010 6:11 pm
Biotech major Biocon on Tuesday settled nearly 13 per cent up on the Bombay Stock Exchange.
